Dr. Scottie's Health Advantage: Antiparasitic Agents and Tumor Response

Dr. Scottie's Health Advantage: Antiparasitic Agents and Tumor Response

Share on X Share on Facebook Share on LinkedIn

This session centers on the biology of parasitic load, pharmaceutical and herbal clearance mechanisms, and the physiological response that occurs when parasites are eliminated at scale.

Dr. Scottie reviews weight-based dosing calculations for ivermectin and fenbendazole, explains the role of binders — including activated charcoal, bentonite clay, zeolite, and fulvic acid — in managing the Herxheimer (die-off) reaction, and outlines timing considerations for supplement separation during a protocol.

The session also covers findings from the largest published observational human study involving ivermectin and fenbendazole in cancer patients, and introduces Dr. Hulda Clark's three-herb framework (black walnut, clove, wormwood) as a maintenance-oriented herbal approach.

This session was recorded on June 22, 2026.

Comments

Sign in or become a Future Forecasters Group member to read and leave comments.